Korea FilingsFull brief — $39

WHANIN PHARM CO.,LTD

환인제약(주) · KOSPI: 016580 · Pharmaceuticals and medicinal chemicals

Key facts

Korean name
환인제약(주)
Market / ticker
KOSPI · 016580
Industry
Pharmaceuticals and medicinal chemicals
Established
1982-12-16
Fiscal year ends
December
Website
www.whanin.co.kr
DART corp code
00166573
Latest revenue
₩255.2B (FY2025)

Items worth checking

medium
Filing on change of largest shareholder or control — filed 2025-10-30.

Financial summary

KRWFY2023FY2024FY2025
Revenue₩230.4B₩259.6B₩255.2B
Operating income₩30.2B₩21.5B₩13.0B
Net income₩29.8B₩23.4B₩13.6B
Total assets₩401.2B₩424.7B₩478.9B
Total liabilities₩43.0B₩48.7B₩57.9B
Total equity₩358.2B₩376.0B₩421.0B
Share capital₩9.7B₩9.7B₩9.7B

Consolidated statements · FY2025 operating margin 5.1% · liabilities to equity 14% · Annual report FY2025 (Korean original)

Auditor opinions

PeriodAuditorOpinion
Term 44 (current)삼정회계법인Unqualified
Term 43 (prior)삼정회계법인Unqualified
Term 42 (two years prior)안진회계법인Unqualified

Largest shareholder history

DateLargest shareholder (Korean)StakeCause (Korean)
2025년 10월 30일이원범증여

Recent filings

DateFilingOriginal
2026-08-13Half-year report (2026.06)DART
2026-07-29Preliminary consolidated operating results (fair disclosure)DART
2026-05-29Corporate governance reportDART
2026-05-13Quarterly report (2026.03)DART
2026-05-11Large shareholding (5%+) reportDART
2026-04-27Preliminary consolidated operating results (fair disclosure)DART
2026-03-23Corporate value-up plan (voluntary)DART
2026-03-20Annual general meeting resultsDART
2026-03-20Independent director appointment / dismissal / resignationDART
2026-03-12Annual report (2025.12)DART
2026-03-12Audit report submittedDART
2026-03-04Notice of shareholders meetingDART
2026-03-03Resolution to convene shareholders meetingDART
2026-03-03Cash / in-kind dividend decisionDART
2026-02-13Revenue or profit structure changed materiallyDART
2026-01-30Fair trade compliance program status (notice)DART
2025-12-22Treasury share disposal results reportDART
2025-12-18Material event report — Treasury share disposal decisionDART
2025-12-15Record date / shareholder register closure setDART
2025-12-15Treasury share disposal results reportDART

Showing the 20 most recent of 31 filings. The full brief lists all of them.

Full brief on WHANIN PHARM CO.,LTD — $39 Get the full brief

For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).

Other Korean companies in Pharmaceuticals and medicinal chemicals

Data generated 2026-09-16 from OpenDART.

This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.